Invites Biocore Co., Ltd. (XKON:216400)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,100.00
-60.00 (-1.90%)
At close: Aug 1, 2025, 3:30 PM KST
-1.90%
Market Cap23.91B
Revenue (ttm)16.96B
Net Income (ttm)667.63M
Shares Out7.71M
EPS (ttm)163.00
PE Ratio19.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,655
Average Volume5,772
Open3,000.00
Previous Close3,160.00
Day's Range2,840.00 - 3,135.00
52-Week Range2,840.00 - 7,790.00
Beta0.36
RSI33.03
Earnings Daten/a

About Invites Biocore

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency tes... [Read more]

Industry Testing Laboratories
Founded 2001
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 216400
Full Company Profile

Financial Performance

In 2014, Invites Biocore's revenue was 16.96 billion, an increase of 29.35% compared to the previous year's 13.11 billion. Earnings were 667.63 million, a decrease of -17.76%.

Financial Statements

News

There is no news available yet.